2008 Barcelona - European Society of Human Genetics

More documents

Recommendations

Info

Author Index 0 P06.009, P08.34 Neghina, A.: P04.080 Negri, R.: P05.033 Negrisolo, S.: P06.274 Negura, A.: P04.031 Negura, L.: P02.214, P04.031 Neigut, D.: C01.4 Neishabury, M.: P01.024 Neitzel, H.: P05.121 Nekkebroeck, J.: EP14.19, P01.347 Nelen, M. R.: P02.067 Nelen, M.: P02.006 Nelke-Lozynska, A.: P06.135 Nelson, N.: P10.21 Nelson, R.: P08.87 Nemtsova, M. V.: P04.127, P04.186 Nenonen, A.: P08.55 Neocleous, V.: P04.195 Neri, G.: P01.093, P02.017, P02.126, P02.211 Neroutsou, R.: P02.160, P03.39 Netesova, O.G.: P06.046 Neto, J. P. D.: P04.160 Neufeld, M. Y.: PL2.4 Neuhann, T.: P01.323 Neuhäuser, G.: P06.059 Neukam, F. W.: P04.175 Neumann, R.: S08.2 Neusser, M.: P02.112 Nevado, J.: P02.094, P05.183 Neveling, K.: P04.144, P05.046 Neves, C.: P08.06 Nevo, Y.: P01.202 Newbury, D. F.: P06.271, P06.272 Newman, P.: C06.5 Newton, R.: C14.6 Nezarati, M. M.: P01.298 Ng, P.: P06.106 Ngendahayo, L.: P01.035 Nicholas, F.: P01.153 Nicholson, J. K.: PL1.1 Nicolás, M.: P01.116 Nicoletti, G.: P05.152, P06.013, P06.084, P06.226 Nicolin, A.: P08.13 Nicoline, H.: P09.01 Niedrist, D.: P01.304 Niel, F.: P01.028 Nielsen, T.: P05.090 Niesler, B.: C08.2, P08.69 Nieto, A.: P01.328, P05.179 Nieto-Martinez, K.: P02.027 Nievelstein, R. J.: P02.090 Niikawa, N.: P05.020, P06.038 Nijmeijer, R. M.: P06.070 Nijpels, G.: EPL1.4 Nikolaev, S. I.: P08.62 Nikolaeva, Y. A.: P03.02 Nikolaishvili, T.: P01.279 Nikolic, A.: P02.220, P06.136 Nikolov, I.: P06.085 Nikonova, T. V.: P05.103 Nikulin, M. P.: P04.146 Nikzat, N.: P05.081 Nili Ahmadabadim, M.: P06.211 Nillesen, W.: P02.006 Nippert, I.: P09.19, P09.31, P09.35 Nishimura, C.: P05.081 Nishimura, D.: P05.010 Nishio, J.: P01.336 Nishio, S.: P09.08 Nitsch, L.: P05.033 Nkenke, E.: P04.175 Noble, B.: P06.105 Noble, J.: P06.294 Nodale, C.: P07.134 Noel-Couillard, S.: P01.324 Nogueira, A.: P02.190 Nogueira, M.: P06.005 Nogueira, R. J.: P10.07 Noguès, C.: EPL3.2, P04.046 Nogushi, T.: P04.046 Nomdedéu, B.: P04.110 Noori-Daloii, A.: P10.14 Noori-Daloii, M.: P10.14 Norambuena, P.: P07.054, P08.40, P09.70 Nordgren, A.: P02.158 Nordin, K.: EPL1.2 Norio, R.: P06.194 Norris, J. M.: P06.083 North, K. N.: P05.087 Norton, N.: P06.195 Noruzinia, M.: P01.060, P04.003 Noskova, T.: P06.026, P06.162 Nöthen, M. M.: P06.261, P08.86, PL2.3 Nouchy, M.: P02.145 Nougayrede, A.: P01.302, P05.047 Novak, M.: P01.355 Novak, N.: P06.032 Novakova, L.: P01.190 Novakovic, I.: P02.220, P04.112, P04.176, P06.047, P06.097, P06.107, P07.015 Novara, F.: C01.1 Novelli, A.: P01.081, P02.041 Novelli, G.: P01.113, P01.215, P01.313, P03.70, P05.138, P06.302, P08.85, P10.19 Novelli, V.: P05.149 Noveski, P.: P02.242, P05.211 Novichkova, G.: P05.041 Novik, G. A.: P01.278, P06.318 Novikov, P. V.: P01.083 Novikova, O. V.: P04.002 Novotna, D.: P01.089 Novotný, T.: P05.109 Nowak, F.: EPL3.2 Nowak, J.: P04.086, P04.166, P06.247 Nowak, M.: P04.169 Nowakowska, B.: P02.042, P06.315 Nowakowska, D.: P04.001, P04.007 Nozza, S.: P05.001 Nucaro, A.: P02.080 Nucera, A.: P05.129 Nudelman, I.: C15.5 Nueganen, K.: P06.165 Nunes, L.: P01.266 Nunes, V.: P01.053, P04.187, P05.116 Núñez Lozano, M.: P05.209 Nurbayeva, T.: P06.020 Nurligayanov, R.: P06.219 Nurmi, H.: P06.101 Nürnberg, G.: P01.361, P06.090 Nürnberg, P.: P01.147, P01.361, P06.175, PL2.3 Nurutdinova, O. S.: C10.4 Nutile, T.: P06.311 Nyberg Godiksen, M. T.: P05.090 Nygren, A.: P06.184 Nyman, E. S.: P07.036 Nyström, A. M.: P01.179 Nyström, M.: P04.017, P08.55 Oancea, R.: P03.43 Obafemi, A. A.: P01.339 Obenauf, A.: P01.365, P02.173, P05.178 Oberkanins, C.: P01.024, P07.016, P08.82 Obersztyn, E.: P01.180, P02.054, P02.095 Obon, M.: P02.065, P02.078 Obralic, N.: P04.202 O‘Brien, K.: P06.206 Ocaña, T.: P04.011 Ochoa, A.: P05.107 Ochoa, C.: EP10.21 Odak, L.: P07.052 O’Dell, S. D.: P06.003 Odent, S.: P01.318, P02.164 Odenthal-Hesse, L.: S08.2 Odinokova, O.: P07.101 O‘Donnell, L.: C01.4, P02.070 O‘Donovan, M.: P06.085, P06.195 O‘Driscoll, C.: P06.254 O‘Driscoll, M.: C12.1 Odunlami, A. O.: EP14.20 Oexle, K.: P05.086 OFDI collaborative group,: P05.149 Ofir, R.: C03.1, P06.317 Ogbah, Z.: P04.139, P04.159, P04.161, P07.085 Ogilvie, C.: P03.28 Ogorodova, L.: P06.028, P06.282 Oguni, H.: P05.107 Ogur, G.: P01.262, P02.098, P02.139, P03.73, P03.74, P03.75, P03.76 Ogur, M. G.: P05.214 Oguzkan Balci, S.: P01.192, P06.145, P06.203 Oh, B.: P06.178
Author Index 0 Oh, T. Y.: P01.084 Ohadi, M.: P06.088 Ohashi, H.: P02.008 Ohta, T.: P06.038 Ohye, T.: P02.205 Oikonomakis, V.: P05.007 Oikonomou, P.: P04.133 Oishi, K.: P01.183 Oitmaa, E.: P02.237 Ojembarrena, E.: P04.016 Okamoto, N.: P01.336, P05.020 Okkels, H.: P07.022 Okuneva, E. G.: P01.281, P05.143 Okur, H.: P05.040 Okur, I.: P01.271 Olafsson, E.: C03.5 Olaru, G.: P01.124 Olasinska-Wisniewska, A.: P06.286 Olavarrieta Scappini, L.: P05.195 Old, R. W.: P03.19, P03.41 Oldak, M.: P01.310 Oldenburg, J.: P05.077 Oldenburg, R.: P06.042 Olenina, L. V.: P05.104 Olga, C.: P06.077 Oliva, R.: P02.234 Oliva-Teles, N.: P02.201 Oliveira, A.: P01.129 Oliveira, G.: P06.034 Oliveira, J. P.: P07.062, P07.094 Oliveira, J.: P01.266, P02.201, P07.008, P08.20 Oliveira, N.: EP12.2 Oliveira, R.: P05.022 Oliveira, S. A.: P05.153, P06.276, P06.277, P08.06 Oliveira, S.: P07.011 Oliveira, T.: P02.105 Oliver, J.: P06.256 Olivier, L.: P09.21 Olivieri, O.: P06.102 Olkkonen, V. M.: C02.5 Olla, N.: P06.140 Ollikka, P.: P03.01 Ollila, S.: P04.017 Olschwang, S.: P04.046 Olsen, R. K. J.: P07.076 Olson, T. M.: P01.342 Olsson-Engman, M.: P01.179 Olszaniecka, M.: P01.080 Olszewski, K.: P05.127, P05.207, P08.83 Oltova, A.: P02.018 Oltra, S.: P02.037, P04.051, P04.167, P04.168 Oltvai, Z.: s12.2 Ommen, S. R.: P01.183 Omrani, M.: P04.203 Omranipoor, R.: P04.047 Onal, B.: P02.167, P02.216, P03.60 Onat, A.: P07.109, P07.126 Onat, O. E.: C07.5 Onay, H.: P01.040, P02.235, P06.167 Onda, H.: P08.61 Oner, O.: P02.167, P02.216, P03.60 Onkamo, P.: P08.55 Onland-Moret, C.: P06.288, P08.78 Ontañón Rodríguez, J. H.: P07.018 Oosterlaan, J.: P06.208 Oosterwijk, J. C.: EPL1.1 Oostra, A.: P02.096 Oostra, B.: P06.149, P06.153, P07.087 Opitz, J. M.: P05.020, P06.059 Oprea, G.E.: PL2.7 Ordonez, A.: P07.072 Ordoñez, E.: P03.15, P03.24, P03.41 Ordoñez, J.: P06.159 Orellana, C.: P02.037, P04.167, P04.168 Orera, M. A.: P02.066, P03.52 Orfao, A.: P04.177 Org, T.: P05.002 Orginac, I.: P01.250 Orgogozo, J.: P01.250 Oriola, J.: P02.234, P04.207 Orioli, I. M.: P06.217 Orkin, S. H.: C08.4 Orlacchio, A.: P06.017, P06.128 Orlova, J.: P06.189 Ormazabal, A.: P01.071 Ormerod, E.: P02.136, P02.171 Ormondroyd, L.: EP01.03, EP07.1 Orosz, P.: P06.069 Oroszlán, T.: P06.173 Orr, H. T.: s09.1 Orrico, A.: P02.017 Orro, A.: C13.6, P07.112 Örs, R.: P02.175 Orsetti, B.: P04.058 Ørstavik, K. H.: P02.009 Ortega, A.: P07.006 Ortega-de-Heredia, M.: P03.43 Ortego-Centeno, N.: P06.279 Ortenberg, E.: P04.192, P08.65 Orteschi, D.: P02.017, P02.126, P02.211 Ortiz, M.: P01.300, P01.301 Ortolan, D.: P02.116 Oruc, L.: P06.246 Osawa, M.: P05.107 Osborn, L.: EPL2.3 Oscar, A.: P07.105 O‘Shea, R.: P09.22 Oshima, A.: P06.306 Osorio, A.: P04.029 Ostadsharif, M.: P08.60 Ostankova, J.: P06.291 Ostergaard, M.: P07.022 Ostergaard, P.: P01.173 Othman, F.: P04.047 Otlowski, M.: EPL5.1 Ott, C. E.: P01.167, PL2.6 Oturai, A.: P06.197 Oudakker, A. R.: P01.085 Ouertani, I.: P01.350, P02.046, P02.089 Õunap, K.: P01.186, P02.034, P02.079, P07.092 Oury, C.: P01.035 Ousati Ashtiani, Z.: P04.047, P04.185 Outeiro, T. F.: s09.3 Oveisi, J.: P02.162, P02.163, P05.122 Oveisi, M.: P03.48 Owen, M.: P06.006, P06.195, P06.085 Oyen, N.: EP13.7 Ozbek, U.: P04.099, P04.100 Ozbinar, A.: P07.038 Ozcelik, T. H.: c07.5 Ozdemir, M.: P04.171, P04.172, P05.045 Ozdilli, K.: P06.203 Ozdogu, H.: P04.114 Ozen, F.: P01.292 Ozen, O.: P04.162 Ozer, F.: P07.038 Ozer, O.: P03.35, P04.162, P09.60 Ozgon, G.: P02.167, P02.216, P03.60 Ozgoz, A.: P05.061, P07.038 Özgül, R. K.: P01.078 Ozhegova, D.: P08.08 Özkan, B.: P06.313 Ozkinay, C.: P04.104, P06.167 Ozkinay, F.: P01.040, P01.305, P02.204, P02.235, P04.104, P05.115, P06.167 Ozretic, P.: P04.068, P07.019 Oztas, T.: P03.75 Ozturhan, H. S.: P06.065 Ozturk, E.: P01.262 Ozyilmaz, B.: P02.098, P02.139, P03.73, P03.74, P03.75, P03.76 Pääbo, S.: s15.1 Pacheco, P. R.: P04.049, P06.044, P06.050, P07.127 Padariyakam, S. M.: P02.130 Padilla, R. A.: P08.71 Pagani, F.: c07.2, P10.09 Paglierani, M.: P04.204 Pagonabarraga, J.: P01.098 Pakravesh, F.: P09.63 Palacín, M.: P01.053, P05.116 Palanca Suela, S.: P04.033, P04.034 Palanca, S.: P04.051 Palau, F.: P01.071, P05.204 Palcevska-Kocevska, S.: P01.338 Paleari, R.: P02.181, P02.208, P03.65 Palka, G.: P02.233, P08.75 Pallares-Ruiz, N.: P05.036 Palleschi, A.: P01.188 Palma, A.: P05.085
Page 1 and 2:
Volume 16 Supplement 2 May 2008 www
Page 3 and 4:
Committees - Board - Organisation E
Page 5 and 6:
Plenary Lectures ESHG PLENARY LECTU
Page 7 and 8:
Plenary Lectures 6 Medical Genetics
Page 9 and 10:
Concurrent Symposia ESHG CONCURRENT
Page 11 and 12:
Concurrent Symposia s04.1 microRNA
Page 13 and 14:
Concurrent Symposia 0 use of positi
Page 15 and 16:
Concurrent Symposia s10.2 Non-invas
Page 17 and 18:
Concurrent Symposia s13.1 Dysregula
Page 19 and 20:
Concurrent Sessions ESHG CONCURRENT
Page 21 and 22:
Concurrent Sessions receptor than t
Page 23 and 24:
Concurrent Sessions an autosomal re
Page 25 and 26:
Concurrent Sessions reporting, and
Page 27 and 28:
Concurrent Sessions c06.3 clinical
Page 29 and 30:
Concurrent Sessions c07.5 VLDLR (ve
Page 31 and 32:
Concurrent Sessions 317,503 single
Page 33 and 34:
Concurrent Sessions MYCN , E2F3 and
Page 35 and 36:
Concurrent Sessions limb or thoraci
Page 37 and 38:
Concurrent Sessions APC, BRCA1 and
Page 39 and 40:
Concurrent Sessions identified 215
Page 41 and 42:
Clinical genetics ESHG POSTERS P01.
Page 43 and 44:
Clinical genetics In Cyprus, the mu
Page 45 and 46:
Clinical genetics gene . Most of th
Page 47 and 48:
Clinical genetics are indeed more d
Page 49 and 50:
Clinical genetics P01.037 Validatin
Page 51 and 52:
Clinical genetics 17 PKU patients f
Page 53 and 54:
Clinical genetics L185R missense mu
Page 55 and 56:
Clinical genetics P01.064 isolation
Page 57 and 58:
Clinical genetics leles- is in acco
Page 59 and 60:
Clinical genetics Sapienza” Unive
Page 61 and 62:
Clinical genetics P01.090 Fragile X
Page 63 and 64:
Clinical genetics P01.099 Deletion
Page 65 and 66:
Clinical genetics other CNPs, the 1
Page 67 and 68:
Clinical genetics FRAXA is the most
Page 69 and 70:
Clinical genetics and PT 19 cm. Nec
Page 71 and 72:
Clinical genetics P01.133 White mat
Page 73 and 74:
Clinical genetics curved radii, uln
Page 75 and 76:
Clinical genetics ered at the 33 rd
Page 77 and 78:
Clinical genetics P01.160 character
Page 79 and 80:
Clinical genetics P01.169 A variant
Page 81 and 82:
Clinical genetics matological anoma
Page 83 and 84:
Clinical genetics sition was identi
Page 85 and 86:
Clinical genetics women ranges by p
Page 87 and 88:
Clinical genetics MD2I or MDC1C sho
Page 89 and 90:
Clinical genetics P01.215 the ctG r
Page 91 and 92:
Clinical genetics pansion . Longer
Page 93 and 94:
Clinical genetics frequency of this
Page 95 and 96:
Clinical genetics mana, CUCS, Unive
Page 97 and 98:
Clinical genetics P01.253 The first
Page 99 and 100:
Clinical genetics consistent findin
Page 101 and 102:
Clinical genetics P01.270 Genetic s
Page 103 and 104:
Clinical genetics P01.279 Dilated c
Page 105 and 106:
Clinical genetics objectives of our
Page 107 and 108:
Clinical genetics P01.298 Hyperphos
Page 109 and 110:
Clinical genetics P01.307 maternal
Page 111 and 112:
Clinical genetics CM in monozygotic
Page 113 and 114:
Clinical genetics P01.325 mowat-Wil
Page 115 and 116:
Clinical genetics P01.334 Identific
Page 117 and 118:
Clinical genetics birth defects is
Page 119 and 120:
Clinical genetics The cause of this
Page 121 and 122:
Clinical genetics were assumed to b
Page 123 and 124:
Cytogenetics P01.369 three novel mu
Page 125 and 126:
Cytogenetics P02.008 Reconfirmation
Page 127 and 128:
Cytogenetics mosomal rearrangement
Page 129 and 130:
Cytogenetics otide-based array plat
Page 131 and 132:
Cytogenetics rangements ranged betw
Page 133 and 134:
Cytogenetics 593 kb microdeletion a
Page 135 and 136:
Cytogenetics We herewith report two
Page 137 and 138:
Cytogenetics cise etiological diagn
Page 139 and 140:
Cytogenetics deleted region contain
Page 141 and 142:
Cytogenetics P02.078 mental Retarda
Page 143 and 144:
Cytogenetics present on the right s
Page 145 and 146:
Cytogenetics P02.096 Delineation of
Page 147 and 148:
Cytogenetics P02.106 Aneuploidy of
Page 149 and 150:
Cytogenetics biologic (cytogenetic)
Page 151 and 152:
Cytogenetics - 60 .0) per 100 cells
Page 153 and 154:
Cytogenetics netic map of deleted r
Page 155 and 156:
Cytogenetics phic at delivery . Min
Page 157 and 158:
Cytogenetics (according to question
Page 159 and 160:
Cytogenetics P02.160 characterizati
Page 161 and 162:
Cytogenetics DISCUSSION: In this st
Page 163 and 164:
Cytogenetics from peripheral blood
Page 165 and 166:
Cytogenetics did not influence upon
Page 167 and 168:
Cytogenetics sented with ambiguous
Page 169 and 170:
Cytogenetics normalities, cytogenet
Page 171 and 172:
Cytogenetics P02.215 cytogenetic an
Page 173 and 174:
Cytogenetics matozoa from carriers
Page 175 and 176:
Cytogenetics of spermatogenesis in
Page 177 and 178:
Prenental diagnostics Genotype Infe
Page 179 and 180:
Prenental diagnostics T21 samples s
Page 181 and 182:
Prenental diagnostics be withdrawn
Page 183 and 184:
Prenental diagnostics The Consortiu
Page 185 and 186:
Prenental diagnostics Here we descr
Page 187 and 188:
Prenental diagnostics service deliv
Page 189 and 190:
Prenental diagnostics cal Universit
Page 191 and 192:
Prenental diagnostics nuchal transl
Page 193 and 194:
Prenental diagnostics etal anomalie
Page 195 and 196:
Cancer genetics forms . The typical
Page 197 and 198:
Cancer genetics P04.012 A novel PtE
Page 199 and 200:
Cancer genetics P04.021 comparative
Page 201 and 202:
Cancer genetics P04.029 characteris
Page 203 and 204:
Cancer genetics mutations detected
Page 205 and 206:
Cancer genetics deleterious mutatio
Page 207 and 208:
Cancer genetics Research Centre, Mo
Page 209 and 210:
Cancer genetics P04.064 Dissection
Page 211 and 212:
Cancer genetics P04.072 Acute promy
Page 213 and 214:
Cancer genetics P04.081 Discordance
Page 215 and 216:
Cancer genetics ity of the malignan
Page 217 and 218:
Cancer genetics Method: mRNA level
Page 219 and 220:
Cancer genetics preparations were o
Page 221 and 222:
Cancer genetics ries.The identifica
Page 223 and 224:
Cancer genetics P04.127 FGFR3 mutat
Page 225 and 226:
Cancer genetics Our experience show
Page 227 and 228:
Cancer genetics way consists of thr
Page 229 and 230:
Cancer genetics and/or prognostic m
Page 231 and 232:
Cancer genetics P04.162 HER-2/neu A
Page 233 and 234:
Cancer genetics controls, by hetero
Page 235 and 236:
Cancer genetics P04.179 molecular g
Page 237 and 238:
Cancer genetics there are no change
Page 239 and 240:
Cancer genetics P04.197 mutation in
Page 241 and 242:
Molecular and biochemical basis of
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Genetic analysis, linkage, and asso
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Normal variation, population geneti
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Genomics, technology, bioinformatic
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Genetic counselling, education, gen
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Therapy for genetic disease 0 proce
Page 435 and 436:
Therapy for genetic disease The die
Page 437 and 438:
Therapy for genetic disease Science
Page 439 and 440:
Therapy for genetic disease P10.26
Page 441 and 442:
EMPAG Plenary Lectures and perceive
Page 443 and 444:
EMPAG Plenary Lectures 0 mutation i
Page 445 and 446:
EMPAG Plenary Lectures EPL5.2 the m
Page 447 and 448:
EMPAG Workshops Methods The matrix
Page 449 and 450:
EMPAG Posters their own home . It e
Page 451 and 452:
EMPAG Posters with resultant specia
Page 453 and 454: EMPAG Posters 0 the family, relativ
Page 455 and 456: EMPAG Posters ties raised by IBMPFD
Page 457 and 458: EMPAG Posters ics, Nicosia, Cyprus,
Page 459 and 460: EMPAG Posters In collaboration with
Page 461 and 462: EMPAG Posters most patients’ psyc
Page 463 and 464: EMPAG Posters 0 EP13.2 Decision mak
Page 465 and 466: EMPAG Posters Objective . GeneBanC
Page 467 and 468: EMPAG Posters EP14.12 the role of t
Page 469 and 470: EMPAG Posters patient (35% vs . 26%
Page 471 and 472: Author Index Al-Owain, M.: P06.160
Page 473 and 474: Author Index 0 Baka, M.: P04.082 Ba
Page 475 and 476: Author Index Berwouts, S.: P09.20,
Page 477 and 478: Author Index P07.117 Buil, A.: P06.
Page 479 and 480: Author Index Cho, J.: P04.192, P08.
Page 481 and 482: Author Index Damy, T.: P01.057 Damy
Page 483 and 484: Author Index 0 Dror, A.: P05.074 Dr
Page 485 and 486: Author Index Fernandez-Real, J.: P0
Page 487 and 488: Author Index P06.310 Gavriliuc, A.
Page 489 and 490: Author Index Grinberg, Y. I.: P01.0
Page 491 and 492: Author Index Hood, L.: PL4.1 Hoogeb
Page 493 and 494: Author Index 0 P02.240, P09.63 Kala
Page 495 and 496: Author Index Kongstad, O.: P09.39 K
Page 497 and 498: Author Index Lee, C.: C13.3 Lee, D.
Page 499 and 500: Author Index Mahjoubi, F.: P02.045,
Page 501 and 502: Author Index P04.196 Meindl, A.: c0
Page 503: Author Index 00 Mottaghi, L.: P01.0
Page 507 and 508: Author Index 0 Peñaloza, R.: P05.2
Page 509 and 510: Author Index 0 Proverbio, M.: P05.0
Page 511 and 512: Author Index 0 Rogers, M.: EP14.18
Page 513 and 514: Author Index 0 Scarcella, M.: P05.0
Page 515 and 516: Author Index P06.179 Sobrino, B.: P
Page 517 and 518: Author Index Taschner, P. E. M.: P0
Page 519 and 520: Author Index Urreizti, R.: P01.050,
Page 521 and 522: Author Index Voegele, C.: P04.121 V
Page 523 and 524: Author Index 0 P04.095, P04.106 Zem
Page 525 and 526: Keyword Index AMACR gene: P04.182 a
Page 527 and 528: Keyword Index cardiac: S04.1 Cardio
Page 529 and 530: Keyword Index Crohn: P07.022 Crohn
Page 531 and 532: Keyword Index evolution: P02.112, P
Page 533 and 534: Keyword Index 0 haemoglobinopathies
Page 535 and 536: Keyword Index KCNJ11: P05.026 KCNQ1
Page 537 and 538: Keyword Index MLH1: P04.010, P04.02
Page 539 and 540: Keyword Index osteochondrodysplasia
Page 541 and 542: Keyword Index PXE-like syndrome: P0
Page 543 and 544: Keyword Index 0 sperm: P02.205 sper
Page 545: Keyword Index venous thrombosis: P0
show all

2008 Barcelona - European Society of Human Genetics

Create successful ePaper yourself

Delete template?

Save as template?